Benign Breast Disease Team Project
No involved investigator sites defined.
To identify women diagnosed with atypical ductal hyperplasia (ADH) who are at increased risk of developing invasive breast cancer (IBC) and who might benefit from risk reduction with the use of chemoprevention agents such as Tamoxifen. (Note: A companion protocol will study women with DCIS and their risk for invasive breast cancer.)
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.